Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.26%
1,099.36
-2.82
-0.26%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.42%
613.66
-2.58
-0.42%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.84%
1,199.75
+10.03
+0.84%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.74%
1,755.66
+29.97
+1.74%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.83%
638.27
-5.35
-0.83%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.76%
844.37
+14.58
+1.76%
829.79832.32844.73832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.84%
215.19
+1.79
+0.84%
213.40213.40216.05213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.62%
3,134.22
-51.70
-1.62%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.46%
931.32
+22.38
+2.46%
908.94912.57932.62912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.21%
1,475.82
-3.14
-0.21%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.08%
2,379.45
-25.91
-1.08%
2,405.362,390.342,402.532,359.18
SWOBY:OTCMKTS
Swedish Orphan Biovitrum ADR
$21.56
0.00%
(0.00) 1D
Apr 20, 12:49:31 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SWOBY...
Mkt. cap
143.18B
Avg. vol.
543.00
Volume
21.00
52-wk high
$23.59
52-wk low
$13.57
Beta
383.98
Shares outstanding
714.83M
No. of employees
2K
News stories
From sources across the web
Profile
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden. In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
About Swedish Orphan Biovitrum ADR
CEOGuido Oelkers
Employees1.86K
Founded1939
Headquarters-
SectorBiotechnology
Websitesobi.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
6.46B
6.18B
7.78B
7.82B
Cost of goods sold
1.50B
1.39B
1.56B
1.51B
Cost of revenue
1.50B
1.39B
1.56B
1.51B
Research and development expenses
834.00M
783.00M
754.00M
879.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.68B
2.74B
2.63B
2.93B
Operating expense
3.52B
3.53B
3.41B
3.75B
Total operating expenses
5.02B
4.93B
4.97B
5.26B
Operating income
1.45B
1.25B
2.80B
2.56B
Other non operating income
1.00M
-
1.00M
-25.00M
EBT including unusual items
1.10B
794.00M
-4.03B
2.17B
EBT excluding unusual items
1.19B
1.03B
2.64B
2.32B
Income tax expense
221.00M
160.00M
-1.13B
310.00M
Effective tax rate
20.16%
20.15%
28.12%
14.27%
Other operating expenses
6.00M
16.00M
26.00M
-57.00M
Net income
875.00M
636.00M
-2.89B
1.86B
Net profit margin
13.53%
10.30%
-37.22%
23.81%
Earnings per share
2.72
2.36
6.05
5.65
Interest and investment income
-
-
-
22.00M
Interest expense
-262.00M
-216.00M
-168.00M
-156.00M
Net interest expenses
-262.00M
-216.00M
-168.00M
-134.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.39B
2.14B
3.71B
3.13B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more